Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide.
about
Nanoemulsions in translational research-opportunities and challenges in targeted cancer therapyMethotrexate carried in lipid core nanoparticles reduces myocardial infarction size and improves cardiac function in rats.Novel formulation of a methotrexate derivative with a lipid nanoemulsion.Reduction of atherosclerotic lesions in rabbits treated with etoposide associated with cholesterol-rich nanoemulsions.mRNA levels of low-density lipoprotein receptors are overexpressed in the foci of deep bowel endometriosis.Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis.Simvastatin increases the antineoplastic actions of paclitaxel carried in lipid nanoemulsions in melanoma-bearing miceAdvances in non-invasive drug delivery for atherosclerotic heart disease.Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.Use of combined chemotherapy with etoposide and methotrexate, both associated to lipid nanoemulsions for atherosclerosis treatment in cholesterol-fed rabbits.Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model.Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits.Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion.Reduction of Atherosclerotic Lesions by the Chemotherapeutic Agent Carmustine Associated to Lipid Nanoparticles.Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size.Evaluation in melanoma-bearing mice of an etoposide derivative associated to a cholesterol-rich nano-emulsion.Formulation of LDL Targeted Nanostructured Lipid Carriers Loaded with Paclitaxel: A Detailed Study of Preparation, Freeze Drying Condition, andIn VitroCytotoxicity
P2860
Q26858849-B62A5FAA-7828-4FA9-BA22-3253105180C9Q33713970-5A363C14-7F3E-4D1B-AEB7-B1BAEA7FCF95Q35488015-36E91552-BA5B-46CB-BF91-7CF0FAC8E23EQ35488032-11CC5E6A-C228-4161-9A73-035C05EC37CFQ36227053-4CFF2D00-E9E2-4091-9417-DEFF0B5312BEQ36518939-96C7B60D-5D9F-4B78-A652-2AFEC1E9E826Q36677466-065C0406-C6E0-4FAA-9A72-452F5FC720DDQ38317205-4627DB7D-6EEE-47DF-B3BF-BF8DD5598A9EQ38965148-8131B0D5-ABB1-4D2A-B441-8E13C544A73BQ39040956-143251CF-BCAC-4F6D-8DA9-216A388C20E1Q39936738-F93EAF5F-B42D-49AB-95D8-33BB1C0FF77FQ41452570-A14D461F-74E0-49CE-B9D1-49DD706369B8Q42709233-57A9D77A-D7A5-4EC2-AC3A-E925F1240EE5Q46877733-C95AB6CF-9ED7-49DD-9702-7156B6F2F0DFQ51507063-26BE8E25-5B54-43B7-8184-A45D08FD2115Q51743444-9E363192-1E9D-4D6F-B79D-46A4D701871FQ53620531-58A6542A-1F4D-40EB-958C-1EBFCD48B980Q58909613-A6E03CA2-49DE-4038-B7A3-7E0B1D7C600A
P2860
Use of a cholesterol-rich microemulsion that binds to low-density lipoprotein receptors as vehicle for etoposide.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Use of a cholesterol-rich micr ...... tors as vehicle for etoposide.
@en
type
label
Use of a cholesterol-rich micr ...... tors as vehicle for etoposide.
@en
prefLabel
Use of a cholesterol-rich micr ...... tors as vehicle for etoposide.
@en
P2093
P2860
P356
P1476
Use of a cholesterol-rich micr ...... tors as vehicle for etoposide.
@en
P2093
Ana C Lo Prete
Carolina H M Azevedo
Claudete J Valduga
Debora G Rodrigues
Denise C Fernandes
P2860
P304
P356
10.1211/0022357022232
P577
2003-12-01T00:00:00Z